nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19
|
Goudswaard, Lucy J. |
|
|
21 |
5 |
p. 1307-1321 |
artikel |
2 |
Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors
|
Ma, Sirui |
|
|
21 |
5 |
p. 1148-1155 |
artikel |
3 |
An updated interactive database for 1692 genetic variants in coagulation factor IX provides detailed insights into hemophilia B
|
Xu, Ziqian |
|
|
21 |
5 |
p. 1164-1176 |
artikel |
4 |
Atorvastatin downregulates plasma procarboxypeptidase U concentrations and improves fibrinolytic potential dose-dependently in hyperlipidemic individuals
|
Claesen, Karen |
|
|
21 |
5 |
p. 1266-1273 |
artikel |
5 |
Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients
|
Kempers, Eva K. |
|
|
21 |
5 |
p. 1177-1188 |
artikel |
6 |
Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in patients with hemophilia
|
Teitel, Jerome |
|
|
21 |
5 |
p. 1104-1106 |
artikel |
7 |
DNA methylation analysis is used to identify novel genetic loci associated with circulating fibrinogen levels in blood
|
Hahn, Julie |
|
|
21 |
5 |
p. 1135-1147 |
artikel |
8 |
Dual roles of fucoidan-GPIbα interaction in thrombosis and hemostasis: implications for drug development targeting GPIbα
|
Shen, Chuanbin |
|
|
21 |
5 |
p. 1274-1288 |
artikel |
9 |
Enhanced metabolic activation of and platelet response to clopidogrel in T cell-deficient mice through induction of Cyp2c and Cyp3a and inhibition of Ces1
|
Jiang, Li-Ping |
|
|
21 |
5 |
p. 1322-1335 |
artikel |
10 |
Exploring phenotypes of deep vein thrombosis in relation to clinical outcomes beyond recurrence
|
Iding, Aaron F.J. |
|
|
21 |
5 |
p. 1238-1247 |
artikel |
11 |
Flipping the script: defining the reversibility of platelet activation
|
Nieman, Marvin T. |
|
|
21 |
5 |
p. 1102-1103 |
artikel |
12 |
Genetic determinants of enhanced von Willebrand factor clearance from plasma
|
Seidizadeh, Omid |
|
|
21 |
5 |
p. 1112-1122 |
artikel |
13 |
Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor
|
Elsheikh, Einas |
|
|
21 |
5 |
p. 1123-1134 |
artikel |
14 |
Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency—first analysis of the International Society on Thrombosis and Haemostasis pediatric antithrombin deficiency database and biorepository
|
Kumar, Riten |
|
|
21 |
5 |
p. 1248-1257 |
artikel |
15 |
Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism
|
Edvardsen, Magnus S. |
|
|
21 |
5 |
p. 1227-1237 |
artikel |
16 |
In vivo effect of rFVIII and rFVIIa in hemophilia A rats evaluated by the Tail Vein Transection Bleeding Model
|
Stagaard, Rikke |
|
|
21 |
5 |
p. 1189-1199 |
artikel |
17 |
Issue Information
|
|
|
|
21 |
5 |
p. e1-e6 |
artikel |
18 |
ISTH News and Updates: Join the ISTH Today
|
|
|
|
21 |
5 |
p. 1393-1394 |
artikel |
19 |
JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte–endothelial proadhesive interactions
|
Beckman, Joan D. |
|
|
21 |
5 |
p. 1366-1380 |
artikel |
20 |
JTH announces six early career authors as recipients of the annual Editors’ Award for 2023
|
|
|
|
21 |
5 |
p. 1075-1076 |
artikel |
21 |
Laboratory international normalized ratios determined with commercial thromboplastins in >450 centers before and after the establishment of the International Standard for human thromboplastin—rTF 16: data from United Kingdom National External Quality Assessment Scheme for Blood Coagulation
|
Kitchen, Steve |
|
|
21 |
5 |
p. 1385-1387 |
artikel |
22 |
Magnetic resonance imaging evidence for subclinical joint bleeding in a Dutch population of people with severe hemophilia on prophylaxis
|
van Leeuwen, Flora H.P. |
|
|
21 |
5 |
p. 1156-1163 |
artikel |
23 |
Optimization of a tail vein transection bleeding model in hemophilia A rats
|
Ivanciu, Lacramioara |
|
|
21 |
5 |
p. 1107-1108 |
artikel |
24 |
Outcomes of venous thromboembolism care: future directions
|
de Jong, Cindy M.M. |
|
|
21 |
5 |
p. 1082-1089 |
artikel |
25 |
Platelet transcriptome analysis in patients with germline RUNX1 mutations
|
Palma-Barqueros, Verónica |
|
|
21 |
5 |
p. 1352-1365 |
artikel |
26 |
Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients
|
Stammler, Romain |
|
|
21 |
5 |
p. 1258-1265 |
artikel |
27 |
Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor-alpha by enzymatic modification of functional arginine residues
|
Thomassen, M. Christella L.G.D. |
|
|
21 |
5 |
p. 1214-1226 |
artikel |
28 |
“Pulmonary embolism response teams: Changing the paradigm in the care for acute pulmonary embolism”: comment
|
Davidson, Bruce L. |
|
|
21 |
5 |
p. 1388-1389 |
artikel |
29 |
“Pulmonary embolism response teams: changing the paradigm in the care for acute pulmonary embolism”: reply
|
Porres-Aguilar, Mateo |
|
|
21 |
5 |
p. 1390-1392 |
artikel |
30 |
Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation
|
Barnes, Geoffrey D. |
|
|
21 |
5 |
p. 1381-1384 |
artikel |
31 |
Repeated platelet activation and the potential of previously activated platelets to contribute to thrombus formation
|
De Simone, Ilaria |
|
|
21 |
5 |
p. 1289-1306 |
artikel |
32 |
Seaweed fucoidan targeting platelet Glycoprotein Ibα: hope from the ocean
|
Wu, Yi |
|
|
21 |
5 |
p. 1100-1101 |
artikel |
33 |
Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation
|
Fang, Lei |
|
|
21 |
5 |
p. 1336-1351 |
artikel |
34 |
SOD2 in platelets: with age comes responsibility
|
Jain, Kanika |
|
|
21 |
5 |
p. 1077-1081 |
artikel |
35 |
Taking aim at titanium ‡
|
Frunt, Rowan |
|
|
21 |
5 |
p. 1109-1111 |
artikel |
36 |
The ISTH SSC Subcommittee on Hemostatic Management of Patients with Liver Disease: goals, ambitions, and call for collaboration
|
Lisman, Ton |
|
|
21 |
5 |
p. 1073-1074 |
artikel |
37 |
Titanium is a potent inducer of contact activation: implications for intravascular devices
|
Litvak, Maxim |
|
|
21 |
5 |
p. 1200-1213 |
artikel |
38 |
Toward gene therapy for congenital thrombotic thrombocytopenic purpura
|
Dekimpe, Charlotte |
|
|
21 |
5 |
p. 1090-1099 |
artikel |